-
"A product like Spotfire can help you visualize that very easily"
-
Business intelligence has evolved to a point where its appeal has spread to a broadening range of organisations. Melbourne-based Walter & Eliza Hall Institute of Medical Research (WEHI) was established in 1916 to engage in immunology research, and today also works in research for cancer and chronic inflammatory diseases.
-
TIBCO Spotfire provides Dana-Farber Cancer Institute with unprecedented insight into cancer vaccine clinical trials.
-
“Spotfire quickly gave us a visual analysis of major trends and main clusters of activity, highlighting neglected areas and graphically pointing out the glaring need of many of these cancers for additional vaccine development.” Vladimir Brusic, Dana-Farber CVC’s Director of Bioinformatics
-
EMBL’s Chemical Biology Core Facility – a joint venture between the European Molecular Biology Laboratory , the German Cancer Research Center(DKFZ) and Heidelberg University – successfully deploys Spotfire software’s interactive and robust analytics capabilities.
-
This is an abbreviated version of the more detailed whitepaper that explores how companies are meeting analytics challenges around the growing number of clinical trials and a wide array of study designs.
-
Pharmaceutical firm places DecisionSite® at the core of its microarray gene expression analysis platform.
-
The clinical graphics solution developed by Insightful is being utilized by GlaxoSmithKline (GSK) to streamline the design, analysis and reporting of clinical trial data. By using the clinical graphics solution, GSK’s Biomedical Data Sciences statistical community is facilitating better scientific analysis and interpretation, and enabling more effective communication across functional areas.
-
The trend toward evidence-based decision-making is taking root in commercial, non-profit and public sector organizations. Driven by increased competition due to changing business models, deregulation or, in some cases, increased regulation in the form of new compliance requirements, organizations in all industries and of all sizes are turning to business intelligence (BI) and data warehousing (DW) technologies and services to either automate or support decision-making processes.
-
This IDC Health Insights Perspective highlights the use of TIBCO Spotfire in the life sciences as the de facto end user interface of choice for the strategic assessment of clinical data.
-
In this webcast, Relay Technology Management demonstrates how the "BD Live!" platform integrates with Spotfire to aggregate and visualize both structured and unstructured data, enabling in stronger portfolio optimization and benchmarking for life science industries.
-
Infinity Pharmaceuticals wanted to increase the quality and speed of its analytical decision making in the discovery of new drug candidates.
Spotfire® DecisionSite™ provided the tools to achieve its goals and reduce the crucial “time to next experiment.”
-
High-performance analytic software technology combined with Motorola’s Six Sigma semiconductor manufacturing legacy optimizes manufacturing processes, geometrically increases product sensitivity, repeatability, and miniaturization and provides an everincreasing level of customer satisfaction. Product yield and quality has increased substantially since the application of Insightful’s advanced analytical software mixed with a unique application of techniques gleaned from Motorola’s experience in semiconductor engineering.
-
Pharmaceutical leader deploys TIBCO Spotfire enterprise analytics platform across its drug discovery organization to catalyze communication and collaboration among
scientists.
-
Leveraging TIBCO Spotfire® data discovery as the front-end and Attivio’s unified information access technology in the back-end, Relay TM developed Business Development Live (BD Live!), a real-time business intelligence and data visualization solution for life sciences professionals. BD Live! aggregates and instantly visualizes structured and unstructured data from more than 27 million data points in real-time, representing a comprehensive list of scientific and business literature, technology transfer data, and clinical trial data.
-
The number of clinical trials underway each year has been increasing steadily, worldwide. With a broad range of study designs, varying data collection methods and time points, efficient data analysis in clinical development has become more important than ever. This whitepaper discusses how companies are meeting the challenges with new analytics approaches.
-
Surromed Inc. is a pioneering biomarker enabled drug discovery and development company and they needed an analysis workflow application for biomarker discovery. With S-PLUS Server and Spotfire DecisionSite they were allowed greater access to analytics and information which improved the quality of decision-making enterprise-wide.
-
This whitepaper outlines How TIBCO Spotfire analytics can guide you down the critical path to greater efficiency in the development of new drugs.
-
At Tularik, Spotfire® DecisionSite™ helps clinical pre-marketing risk analysts get a jump on spotting adverse event risks—before they adversely affect the bottom line.
-
“We selected S+ArrayAnalyzer because it offered our research team the flexibility and extensibility to customize an analytic-rich solution to meet the unique needs of
our diverse research team,” said Dr. Markus Loeffler.
-
DecisionSite™ for Functional Genomics®’ data integration capabilities have opened up new analytic opportunities for UW’s biomedical researchers.
-
Drug discovery and development can be time consuming and expensive. Each year, the global pharmaceutical industry spends at least $10 billion on clinical trials. To counter this expense, next-generation statistical software provides pharmaceutical scientists with the tools they need to discover hidden knowledge buried in data collected during clinical trials. The use of software tools with powerful graphical and modeling capabilities, such as S-PLUS, result in better and faster drug development.
-
“Previously, it was difficult to identify trends in the large amounts of screening data generated, including systematic issues. With TIBCO Spotfire, we can visualize our results in a real-time dashboard, identify and exclude the systematic errors as they occur, and run repeat samples as required. We’ve reduced Hit Discovery data processing by more than 65 percent.” Dr. Kurt Lackovic, Senior Research Officer, Walter + Eliza Hall Institute of Medical Research